Vyome Holdings, Inc (HIND): Total Liabilities
$2.74M
As of 2025-12-31
$1.86M
As of 2026-06-30
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.74M | -52.6% | 2026-03-18, Balance as of period end |
| 2024-12-31 | $5.77M | n/c | 2026-03-18, Balance as of period end |
| 2023-12-31 | $4.00M | -46.5% | 2025-04-04, Balance as of period end |
| 2022-12-31 | $7.48M | n/a | 2024-04-01, Balance as of period end |
| 2022-09-30 | $7.53M | n/a | 2023-04-17, Balance as of period end |
| 2022-06-30 | $9.58M | n/a | 2023-04-17, Balance as of period end |
| 2022-03-31 | $8.66M | n/a | 2023-04-17, Balance as of period end |
| 2021-12-31 | $8.20M | -63.7% | 2023-04-17, Balance as of period end |
| 2020-12-31 | $22.57M | +396.8% | 2022-04-08, Balance as of period end |
| 2019-12-31 | $4.54M | -73.7% | 2021-03-12, Balance as of period end |
| 2018-12-31 | $17.28M | -3.9% | 2020-02-27, Balance as of period end |
| 2017-12-31 | $17.99M | +24.3% | 2019-02-22, Balance as of period end |
| 2016-12-31 | $14.47M | -1.3% | 2018-03-05, Balance as of period end |
| 2015-12-31 | $14.66M | n/a | 2017-02-23, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | 2025-12-31 | $2.74M | -52.6% |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | $8.43M | -22.2% |
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | $7.00M | +0.4% |
| Abvc Biopharma, Inc. (ABVC) | 2025-12-31 | $7.76M | +13.9% |
| Medicinova Inc (MNOV) | 2025-12-31 | $4.02M | +19.1% |
| Scienture Holdings, Inc. (SCNX) | 2025-12-31 | $14.06M | -45.5% |
| Regen BioPharma Inc (RGBP) | 2025-09-30 | $6.56M | +21.9% |
| Mereo BioPharma Group plc (MREO) | 2025-12-31 | $5.00M | -67.6% |
| Clene Inc. (CLNN) | 2025-12-31 | $35.72M | -1.3% |
Compare HIND, ALLR, PVCT, ABVC side by side · Screen every company in Pharmaceutical Preparations ↗